User Testing

RRG offer a high quality and flexible Patient Information Leaflet (PIL) User Testing Service.  We recognise the importance of keeping to a tight budget whilst ensuring the highest quality is maintained.  We offer two levels of service, Basic and Comprehensive.

Our Basic Service includes:

  • Initial Client Consultation
  • Minor re-write of leaflet (up to 4 hours)
  • Preparation of protocol
  • Pilot test
  • Round 1
  • Round 2
  • Final Report (e copy)
  • Client liaison (up to 2 hours) 

Comprehensive Service:

Our Comprehensive Service includes all of the Basic Service elements with the addition of a number of tailored services designed to suit our client’s needs.

  • Strategy
    • Focused Testing
    • Justification for not testing
    • Timing of UT results in relation to submission assessment of application
  • Harmonisation
    • Across a product range
    • Across a set of countries
  • Leaflet Text Amendment
    • SPC/Leaflet comparison
    • Reformatting to QRD template
    • Writing/rewriting of leaflet
  • Leaflet mock-up
    • Design
    • Production
    • Amendment
  • Bridging Reports
  • Client liaison


Our team will advise on the regulatory framework of the PIL and how it should be tested. We are continually making submissions which means, we are able to give you the most up to date advice ensuring your leaflet is approved in the fastest possible time.

Expertise to help you get your message across to patients

Our specialists have extensive experience managing the right information for the right people. RRG believes that clear simple statements help people to understand information. We therefore use medical information expertise to help develop the optimal wording for your leaflet.




Contact Us

T: +44 (0)1276 671 166
F: +44 (0)1276 670 960

Email Us

Find Us

RRG, Innovation House
Albany Park, Camberley
Surrey. GU16 7PL

View Map

Latest News

We have placed cookies on your computer to help make this website better. You can change your cookie settings at any time. Otherwise, we'll assume you're OK to continue.